Skip to main content
. 2021 Mar 25;13(7):1505. doi: 10.3390/cancers13071505

Figure 2.

Figure 2

Immunophenotype of a B-cell acute lymphoblastic leukemia (B-ALL) tissue microarray cohort. (A) Expression of IGF2BP3 according to the WHO classification of B-ALL. (B) Positivity to IGF2BP3 among cases with either a negative or positive expression of the BCL6 protein. (C) Positivity to IGF2BP3 in cases with negative or positive CD34. (D) Positivity to IGF2BP3 in cases with a negative or positive pSTAT5 (Y694). (E) Expression of Ki-67 among cases with either a low or high IGF2BP3 (median as a cut-off). Dots depict outliers. p-values of (B–E) Mann–Whitney U test and (A) Kruskal–Wallis test are shown.